{"version":"1.0","provider_name":"Canadian Partnership Against Cancer","provider_url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/","author_name":"Catherine","author_url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/author\/cjan\/","title":"Cadre pour optimiser les taux de rappel pour anomalie dans le d\u00e9pistage du cancer du sein - Canadian Partnership Against Cancer","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"G2dWq1pu5D\"><a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/\">Cadre pour optimiser les taux de rappel pour anomalie dans le d\u00e9pistage du cancer du sein<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/embed\/#?secret=G2dWq1pu5D\" width=\"600\" height=\"338\" title=\"&laquo;&nbsp;Cadre pour optimiser les taux de rappel pour anomalie dans le d\u00e9pistage du cancer du sein&nbsp;&raquo; &#8212; Canadian Partnership Against Cancer\" data-secret=\"G2dWq1pu5D\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.partnershipagainstcancer.ca\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"En mati\u00e8re de d\u00e9pistage du cancer du sein, le taux de rappel pour anomalie est le pourcentage de mammographies interpr\u00e9t\u00e9es comme anormales et n\u00e9cessitant donc des examens suppl\u00e9mentaires. Si le TRA est trop faible, un certain nombre de cancers ne seront pas d\u00e9tect\u00e9s; s\u2019il est trop \u00e9lev\u00e9, on demandera \u00e0 certaines personnes de passer des [&hellip;]","thumbnail_url":"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/08\/Woman-on-ACR-cover-700x400-1.jpg"}